In our study, ALT ≥ 18.2 U/L was proved to be independently related to NAFLD, which indicated that elevated ALT within the normal range should also be of concern, especially in high-risk patients such as those who are overweight. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.